Our expert team provides comprehensive clinical care and treatment for children, adolescents and young adults with cancer and blood disorders.
The Johns Hopkins All Children’s Cancer & Blood Disorders Institute offers a variety of programs and services, including:
Adolescent & Young Adult Oncology Program
Johns Hopkins All Children's expanding Adolescent and Young Adult (AYA) Oncology Program addresses the unique medical and psychosocial aspects of teenagers and young adults dealing with cancer. The goal of the AYA program is to help teens and young adults understand and adjust to the impact of cancer on their developing bodies and lives.
Sickle cell program provides comprehensive care to patients from birth to age 21, including access to new therapies, chronic transfusion regimens and stem cell transplant.
Hemophilia treatment center offers the shared expertise of specialists in hematology, pharmacy, orthopaedics, nutrition, social work and physical therapy.
Pediatric thrombosis clinic is led by Neil Goldenberg, M.D., Ph.D., recognized nationally for his research in this field. We offer a comprehensive stroke program and are leaders in the prevention of thrombotic complications for children of all ages.
Bone marrow failure program offers evaluation and treatment for patients with bone marrow failure syndromes, including, if necessary, stem cell transplantation.
Blood & Marrow Transplant
We are Florida’s largest pediatric blood and marrow transplant program with excellent outcomes, offering all forms of hematopoietic stem cell transplantation to treat malignancies, bone marrow failure, primary immunodeficiency diseases and inborn errors of metabolism. The team works collaboratively with the hematology-adult hematology-oncology colleagues at Moffitt Cancer Center and shares FACT (Foundation for Accreditation of Cellular Therapies) accreditation through Moffitt as its sole pediatric affiliate.
CanSurvive is a cancer survivorship clinic that provides coordinated multidisciplinary survivorship care, including annual visits with doctors (including pediatric oncologists and other pediatric subspecialists), an oncology social worker and other members of Johns Hopkins All Children’s wellness team.
In order to be seen in the CanSurvive Clinic, patients must be in clinical remission at least five years from their most recent cancer diagnosis, and at least two years from completion of their last therapy. Additionally, patients who have undergone bone marrow transplantation for a cancer or noncancerous illness can be seen in our clinic.
Center for Cell and Gene Therapy for Non-Malignant Conditions
The Center brings together specialists in immunology, hematology, oncology, bone marrow transplant, and other areas of medicine with experience in diagnosing and treating rare disorders through transplantation, including hemoglobinopathies such as sickle cell disease and thalassemia; severe combined immunodeficiency (SCID) and leaky SCID; non-SCID primary immunodeficiencies; immune dysregulation disorders; bone marrow failure syndromes; and other rare disorders.
Our Neuro-Oncology Program is dedicated to providing our patients with high-quality, personalized care and offers a variety of services, including high-tech neuro-imaging and complex brain and spinal tumor surgery.
Our program participates in precision and individualized medicine to discover genetic and molecular aspects of central nervous system tumors to tailor the treatment and chemotherapy protocols for each patient. We are also dedicated to preserving all motor abilities, vision, hearing and cognitive functioning and offer experimental research clinical trials when appropriate.